Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Otsuka Pharmaceutical is looking to banish paper from clinical trials by working to prepare a 100% e-platform for use in Phase III.
Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.
Daiichi Sankyo has struck a deal to use Veeva Systems’ cloud platform to store its eTMFs and other R&D files.
The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.
Google's Art Levinson-helmed biotech Calico has hired Daphne Koller to build and lead its computational biology and machine learning team.
Synthego has emerged from stealth mode equipped with guide RNA products for use in CRISPR/Cas9 genome engineering.
The team that founded Firecrest Clinical and led it to a takeout by CRO Icon has raised $6 million for its next startup, teckro.
TrialReach has named former Google Ventures Europe partner Eze Vidra as its chief innovation officer.
Florence Healthcare has picked up seed funding to help clinical trial sites switch from paper files to the cloud.
Pfizer has delivered a clear indication of the research potential of 23andMe’s massive database by finding 15 genetic loci linked to risk of major depression.